Loading…
avatar for Peter Mesenbrink

Peter Mesenbrink

Novartis Pharmaceuticals Corporation, United States
Executive Director of Biostatistics
Peter Mesenbrink, PhD is an Executive Director of Biostatistics at Novartis Pharmaceuticals Corporation in East Hanover, New Jersey. Peter received his BS in Mathematics from UVM in 1989 and a PhD in Statistics from NCSU in 1995. He joined Novartis in 1995 and is currently Therapeutic Area Head of Biostatistics for Rheumatology. He is an active member and leader within IMI EU-PEARL. Peter has research interests in statistical methodology for estimands/handling of missing data, design of master protocols, and meta-analysis methods. He is currently on the Board of Directors for the Clinical Research Data Alliance to improve how we share data within the scientific community.
  • Timezone
  • Filter By Date DIA 2022 Global Annual Meeting Jun 13 -23, 2022
    • June 2022
      SunMonTueWedThuFriSat
       1234
      567891011
      12131415161718
      19202122232425
      2627282930 
  • Filter By Venue Chicago, IL, USA
  • Filter By Type
  • 00: Plenary
  • 01: ClinSafety-PV
  • 02: ClinTrials -ClinOps
  • 03: Data-Tech in Clinical Trials
  • 04: MedAffairs-SciComm
  • 05: Patient Engagement
  • 06: PreClinical Dev-EarlyPhaseCR
  • 07: ProjectManagement-StrategicPlanning
  • 08: RD Quality-Compliance
  • 09: Regulatory
  • 10: RegCMC-Product Quality
  • 11: Statistics
  • 12: Value-Access
  • 13: ProfDevelopment
  • 14: DIAmond
  • 15: Content Hubs
  • 16: Community Rounds
  • 17: Networking Opportunities
  • 18: Posters
  • 19: InnovationTheaters
  • 20: Short Courses
  • Level
  • Featured Topics